Skip Navigation
Department of Health and Human Services www.hhs.gov
  • Home
  • Search for Research Summaries, Reviews, and Reports
 
 
Maintenance Notice
An infrastructure upgrade will take place on Friday, December 19 at approximately 2PM Eastern time. Please be aware you may experience temporary issues accessing the site at that point.

Executive Summary – Aug. 24, 2012

Closing the Quality Gap Series: Bundled Payment: Effects on Health Care Spending and Quality

Formats

Table of Contents

Background

his review is part of the Closing the Quality Gap: Revisiting the State of the Science series, which aims to provide critical analysis of the existing literature on quality improvement strategies for a selection of diseases and practices. The review focuses on “bundled payment,” a strategy for health care quality improvement and cost containment. This strategy has been the subject of increasing interest, with the Centers for Medicare & Medicaid Services announcing a large national bundled payment initiative in August 2011. Other reviews in the series will address a range of quality improvement topics arising from portfolios (areas of research) of the Agency for Healthcare Research and Quality (AHRQ).

We define “bundled payment” as a method in which payments to health care providers are related to the predetermined expected costs of a grouping, or “bundle,” of related health care services. In contrast, fee-for-service payment typically involves payments for individual services, while capitation involves a single per capita prospective payment for all services over a fixed period of time, regardless of the number of services or episodes of care provided within that period. Within the bundled payment model, a variety of specific payment methods are possible. Bundles may be defined in different ways, covering varying periods of time and including single or multiple health care providers of different types. In addition, given the diversity and complexity of the U.S. health care delivery system, bundled payment programs may be implemented in a variety of contexts that may influence their effects on spending and quality.

Bundled payment should create a financial incentive for providers to reduce the number and cost of services contained in the bundle.1 Providers are typically given discretion over the allocation of the services used to treat the patient’s episode most effectively. This flexibility may encourage providers to use resources to coordinate care; often, these services are not reimbursed under fee-for-service payment. If the bundle includes services delivered by multiple providers in multiple settings, providers have to create a mechanism for managing the shared payment for a given treatment or condition, which could also foster coordination.1

Several types of undesired effects of bundled payment have also been postulated. The most significant potential undesired effects include underuse of effective services within the bundle, avoidance of high-risk patients, and an increase in the number of bundles reimbursed (increasing health spending). Providers under bundled payment may “game” the system by changing coding practices to maximize reimbursement for the bundle (“upcoding”) or by moving services in time or location to qualify for separate reimbursement (“unbundling”).

Objectives

This review was designed to address the uncertainties about the effects of bundled payment on spending and quality measures. It should help readers (1) understand what the evidence shows about the effects of bundled payment on health care spending and quality of care, and (2) understand key design and contextual features of bundled payment programs and their association with bundled payment effects.

The review addressed three Key Questions:

  1. What does the evidence show on the effects of bundled payment versus usual (predominantly fee-for-service) payment on health care spending and quality measures?
  2. Does the evidence show differences in the effects of bundled payment systems by key design features?
  3. Does the evidence show differences in the effects of bundled payment systems by key contextual factors?

Conceptual Framework

We use the conceptual model in Figure A to understand these Key Questions. This model is based on ones developed by Dudley et al.2 and Andersen3 to describe organizations’ response to payment incentives in general2 and in the context of access to health care specifically.3

Several key design features define a particular set of incentives and disincentives associated with any specific bundled payment strategy. The impact of these design features is addressed by Key Question 2. The financial and nonfinancial characteristics of these incentives are primary determinants of an organization’s need to change practice in response to the modified payment policy. This response, however, may be mediated by key contextual factors, including both predisposing and enabling factors. Predisposing factors include the general financial environment (such as baseline levels of financial performance and efficiency), other incentives outside of the bundled payment program, market variables, and characteristics of participating provider organizations (such as charter and mission). Enabling factors include the capabilities and goals of participating organizations and the degree to which these organizations are integrated, as well as staff and patient characteristics. The impact of these contextual factors is addressed by Key Question 3. The center of the model reflects how organizations respond to the incentives created by bundled payment in both desirable and undesirable ways. Key Question 1 addresses how different potential responses affect study outcomes, including health care spending and health care quality.

Figure A. Conceptual model for review of the effects of bundled payment strategies on health care spending and quality of care

Figure A. Conceptual model for review of the effects of bundled payment strategies on health care spending and quality of care

Source: Authors’ modification of conceptual models by Dudley et al.2 and Andersen.3
Note: KQ = Key Question.

Methods

Topics for the Closing the Quality Gap: Revisiting the State of the Science series were solicited from the portfolio leads at AHRQ. The nominations included a brief background and context, the importance of and/or rationale for the topic, the focus or population of interest, relevant outcomes, and references to recent or ongoing work. Among the topics that were nominated, the following considerations were made in selection for inclusion in the series: the ability to focus and clarify the topic area appropriately, relevance to quality improvement and a systems approach, applicability to the Evidence-based Practice Center program/amenability to systematic review, potential for duplication and/or overlap with other known or ongoing work, relevance and potential impact in improving care, and fit of the topics as a whole in reflecting the AHRQ portfolios.

A Technical Expert Panel reviewed and provided input on topic definition, Key Questions, the search strategy, and preliminary search results. A draft report was reviewed by 11 peer reviewers and posted for public comment.

Studies published between January 1, 1985, and January 17, 2011, that address the Key Questions described above were included. The following studies were excluded: (1) studies that did not report any of the outcomes of interest; (2) studies that did not report on a bundled payment intervention as defined above; (3) background articles or articles strictly limited to describing theoretical models. Studies of interventions implemented in countries other than the United States were included if they met broad criteria for generalizability to the United States, such as implementation in a health care delivery organization comparable to one found in the United States.

A librarian performed the initial literature search. One trained reviewer, with input on questionable titles from a second trained reviewer, scanned the titles and abstracts of the list generated by the librarian and selected studies for full-text screen. For each of the selected studies, reviewers performed further reference mining by scanning titles listed in the reference section to identify additional articles to be included. Reviewers reconciled their selections and made joint decisions, following the inclusion/exclusion criteria listed above. Given the large and relatively older body of research on the Medicare Inpatient Prospective Payment System, the researchers, in consultation with AHRQ and the Technical Expert Panel, chose to consider a review of review articles for the assessment of this program.

We summarized the evidence for effectiveness and risks of bundled payment in comparison with usual payment methods. We present the results in a narrative synthesis and evidence tables (Appendix A).

We assessed the methodological quality of individual studies and reviews as good (low risk of bias), fair, or poor (high risk of bias). Studies rated “poor” or “good” were also given a brief explanation of the basis for the rating. The rating was based on criteria developed by AHRQ.4 We also rated the overall strength of the evidence using methods adapted by AHRQ from the GRADE (Grading of Recommendations Assessment, Development and Education) Working Group and assessed the overall applicability of the studies reviewed.4

Results

We reviewed 58 studies, excluding studies of the Medicare Inpatient Prospective Payment System (IPPS), for which we reviewed 4 review articles. Among the reviewed studies, 48 employed observational designs, while 9 were descriptive. Only one study was randomized at the provider level,5 and we identified no studies of bundled payment programs randomized at the patient level. The included studies examined 20 different bundled payment interventions. Most articles examined U.S. public insurance prospective payment systems or international prospective payment systems. All but three of the bundled payment interventions in the included studies included public payers only. Bundled payment interventions may aggregate costs longitudinally (i.e., over time within a single provider), aggregate costs across providers, and/or involve warranties by which the costs of complications are rolled into a single payment. All but 4 of the 20 bundled payment interventions involved bundling of services during a period of time by a single provider, such as a hospital, skilled nursing facility, or home health provider.

Our search identified other bundled payment programs in progress, including the Medicare Acute Care Episode demonstration, PROMETHEUS Payment®, and others. However, we did not identify published evaluations of these programs that met our inclusion criteria. We briefly describe several of these programs in this review.

Despite the heterogeneity of settings, interventions, study designs, and measures used, reviewers noted relatively consistent impacts of bundled payment on spending and quality measures (Key Question 1), which are summarized below. Few studies explicitly included analyses of differential effects by key contextual factors (Key Question 3), and none included analyses of differential effects by key design features (Key Question 2). We did not attempt to address Key Questions 2 and 3 through comparisons across interventions because these analyses would be limited by the heterogeneity of the interventions and evaluation methods. Table A summarizes the studies included in the review, followed by our assessments of the evidence for each Key Question. The majority of studies were of U.S. public insurance prospective payment systems.6-51 The remainder of the studies were of a U.S. private-sector single-setting payment system,52,53 international bundled payment systems,54-62 and U.S. bundled payment systems including multiple providers or sites of care.63-66

Table A. Bundled payment systems in included studies
Payment System No. of Included Studies Intervention Date Payer Provider Type(s) Services Included in Bundle
a Implementation was delayed in four States.
Source: Authors’ analysis of search results.
U.S. Public Insurance Prospective Payment Systems
Medicare Inpatient Prospective Payment System 46-9 (reviews) October 1983a Medicare Inpatient hospitals Per-discharge payment for hospital costs associated with each diagnosis-related group (including nursing, accommodation, etc.) and outpatient services in 3 days prior to admission.
Medicare Skilled Nursing Facility Prospective Payment System 2010-29 July 1998 Medicare Skilled nursing facilities Per diem payment for routine, ancillary, and capital-related skilled nursing services for each of 56 resource utilization groups.
Medicare Inpatient Rehabilitation Facility Prospective Payment System 1111,19,30-38 January 2002 Medicare Inpatient rehabilitation facilities Per-discharge payment for operating and capital costs for each of 92 case-mix groups.
Medicare Home Health Prospective Payment System 12 5,11,19,39-47 October 2000 Medicare Home health agencies Payment per 60-day episode for all nursing care, therapy, and aide services for each of 153 Home Health Resource Groups.
Medicare Long-Term Acute Care Hospital Prospective Payment System 148 October 2002 Medicare Long-term acute care hospitals Per-discharge payment for all operating and capital costs for each of 318 Medicare long-term care diagnosis-related groups.
Department of Veterans Affairs Resource Allocation Methodology 149 1985-88 Department of Veterans Affairs Inpatient hospitals Per-admission payment (diagnosis-related groups) for hospital services.
Maine Medicaid Nursing Home Prospective Payment 150 1982-85 Maine Medicaid Nursing homes Per diem payment for nursing home services (patient care, dietary care, lodging, etc.).
New Hampshire Medicaid Hospital Prospective Payment 151 January 1989 New Hampshire Medicaid Inpatient hospitals Payment includes per-discharge prospective component based on diagnosis-related group as well as an actual costs component.
U.S. Private-Sector Single-Setting Bundled Payment System
Case Rate for Managed Behavioral Health Care 252,53 July 1995 Single U.S. managed behavioral health care organization Psychiatrists, psychologists, social workers All outpatient mental health services for 1 year following referral.
International Bundled Payment Systems
Belgium Inpatient Prospective Payment System 154 1995 Belgian public health insurance Inpatient hospitals Per-admission payment for nonmedical hospital services (e.g., nursing staff, accommodation) for each of 604 case-mix groups.
National Health Service (England) Payment by Results 155 2003 English National Health Service Hospitals Hospital services. (More detail not reported.)
Italy Inpatient Prospective Payment 156 January 1995 Italian Ministry of Health Inpatient hospitals Hospital and physician services. (More detail not reported.)
Japan Outpatient Hemodialysis Bundled Payment 157 April 2006 Not reported Dialysis clinics and hospitals Dialysis drugs. (More detail not reported.)
Netherlands Inpatient Prospective Payment 158 2005 Not reported Inpatient hospitals Hospital and physician services. (More detail not reported.)
Sweden Inpatient Prospective Payment System 159 1992 Stockholm County Council Inpatient hospitals Hospital services. (More detail not reported.)
Taiwan Hospital Case Payment 360-62 October 1997 Taiwan National Health Insurance Bureau Hospitals Per-episode payment for required medical services, “optional” medical services, pharmaceuticals, and evaluations within a 2-week period for surgeries.
U.S. Bundled Payment Systems Including Multiple Providers/Sites of Care
Geisinger ProvenCareSM 163 February 2006 Geisinger Health Plan, PA Three demonstration hospitals Per-discharge payment for evaluation, hospital, and professional fees; routine postdischarge care; management of complications.
Medicare Participating Heart Bypass Demonstration 164 May 1991-June 1996 Medicare Seven demonstration hospitals Per-discharge payment for all inpatient hospital and physician services, including related readmissions.
Medicare Cataract Surgery Alternative Payment Demonstration 165 1991-April 1996 Medicare Four demonstration sites Preoperative diagnostics and evaluation, surgical services, postoperative exams to 120 days, management of common complications.
Michigan Arthroscopic Surgery Bundling Pilot With Warranty 166 April 1987 Blue Care Network (Blue Cross Blue Shield of MI) Single surgical practice and hospital Single payment for all care related to surgery, including repeat surgery, repeat hospitalization, or any other related services rendered by the providers for 2 years.

Key Question 1: Impact of Bundled Payment on Health Care Spending and Quality Measures

The published evidence suggests that transitioning from cost-based or fee-for-service payment to bundled payment resulted in declines in spending and utilization, with small changes in quality measures that were in different directions. The evidence suggests that the transition from a cost-based or fee-for-service reimbursement to bundled payment was generally associated with a decline in spending of 10 percent or less. Bundled payment was associated with a decrease in utilization of services included in the bundle, often measured as reductions in length of stay or utilization of specific services (5-percent to 15-percent reductions in many cases).

The inconsistency in findings on quality measures included both differences in the direction and magnitude of effects on different quality measures within a single study and differences in the direction and magnitude of effects for similar quality measures between studies. For a given bundled payment intervention, either some quality measures improved while others worsened or studies arrived at different conclusions about the effect of bundled payment on related quality measures. Little evidence was reported about other potential negative consequences of bundled payment, although studies of several programs noted that bundled payment programs resulted in shifts of utilization to other settings of care.

Overall, reviewers graded the strength of evidence for this Key Question as “low,” indicating that there is low confidence that the evidence reflects the true effect, and that further research is likely to change our confidence in the estimate of effect and is likely to change the estimate. This rating was based primarily on reviewers’ assessments that the included studies were, as a whole, at high risk of bias and residual confounding, although the expected direction of the effect of residual confounding could not be assessed. The results of included studies were consistent in the direction of the effect for spending and utilization measures but inconsistent for quality measures. Based on the consistency of findings across heterogeneous interventions and evaluations, it is likely that the direction of the observed effects on spending and utilization measures would not change in future studies, although the magnitude of the effect could change in studies employing different methods for addressing bias and confounding.

Key Question 2: Differential Effects by Key Design Features

No studies explicitly tested the effect of intervention design features, such as variations in the set of services included in a bundle, on spending or quality measures. We did not perform comparisons of design-feature impacts across studies because of the heterogeneity of the bundled payment programs studied. We do, however, provide some discussion of the potential impact of design features on study outcomes. Reviewers graded the evidence for this Key Question as insufficient to permit an estimation of effects due to the lack of evidence.

The reviewed studies included a heterogeneous set of bundled payment programs. Reviewed payment systems differed in the degree to which the bundled payment applied to multiple independent providers and/or provider types. Only the Medicare Participating Heart Bypass Demonstration, Medicare Cataract Surgery Alternative Payment Demonstration, Michigan Arthroscopic Surgery Bundling Pilot, and Geisinger ProvenCareSM Program integrated physician payments with hospital payments when these payments were previously separate. Studies of these programs found evidence for reduced spending with inconsistent effects on different quality measures. However, there was limited basis for a comparison of the magnitude of these findings with the magnitude of findings from studies of bundled payment interventions that apply to a single institutional provider. The two Medicare demonstrations reported some difficulty in administration of the bundled payment programs, in part due to challenges of distributing payment among the multiple providers participating in the bundled payment.

Overall, the reviewed payment systems employed a variety of bundle definitions that were tailored to the relevant care setting. Risk adjustment and separate outlier payments were common, with methods varying among programs.

Quality metrics or incentives were rarely integrated into bundled payment systems. Despite the potential for undesired effects of bundled payment on quality of care, programs generally did not include quality as an intrinsic part of the bundled payment mechanism. Among the programs reviewed, only the Geisinger ProvenCareSM Program integrated pay-for-performance components into a bundled payment system, and therefore no differential effects across evaluations can be reported for this design feature. It is possible that inclusion of quality-related incentives as a component of future bundled payment programs will change providers’ response to the program in a way that impacts quality measures, but the effect is unknown at this time. Other programs used quality measurement in program monitoring and evaluation or as a criterion for program participation but not as a component of the payment method. Many of the bundled payment programs studied were implemented prior to the recent proliferation of pay-for-performance programs. The science of health care quality measurement and quality incentives has developed since many of the programs were implemented. In some cases, the bundled payment programs reviewed will be accompanied in the future by a separate pay-for-performance program that addresses the same providers and services. It is unclear how these pay-for-performance programs will interact with the bundled payment programs studied or the differential impact on quality of including the quality-related incentives as an integrated part of bundled payment or as a stand-alone program. Among more recent bundled payment programs that have been announced or initiated but not yet evaluated, some use quality measurement in a monitoring and evaluation role (e.g., Medicare national bundled payment initiative), while others incorporate pay-for-performance with the bundled payment (e.g., PROMETHEUS Payment).

Reviewed payment systems also differed in their approach to establishing initial bundle reimbursement rates. Historical expenditures were typically used to determine the initial bundled payment rates, but programs differed in whether the bundled payment rate was set at an amount estimated to increase, decrease, or maintain historical expenditure levels.

Several reviewed studies either directly studied the implementation process of one or more bundled payment systems or included implementation-related anecdotes. Most studies providing survey or anecdotal evidence from providers noted that new bundled payment systems faced significant initial resistance from providers.

Key Question 3: Differential Effects by Key Contextual Factors

The effects of most key contextual factors were not addressed by any reviewed studies. Several studies compared differential effects of bundled payment on spending among for-profit and not-for-profit providers. In general, for-profit providers experienced larger declines in utilization under bundled payment than their not-for-profit counterparts (including U.S. and non-U.S. hospitals, skilled nursing facilities, inpatient rehabilitation facilities, and home health agencies).22,23,25,35,38,43,57 The four review articles on the Medicare IPPS reported that hospitals under greater financial pressure had greater reductions in utilization in response to IPPS.

Several studies reported outcomes separately for patients with relatively severe disease or injury and patients with less severe disease or injury, but the results were inconsistent between studies. One study reported different impacts of bundled payment on spending and utilization by geographic area but did not provide an explanation of this differential impact.

For the effect of three specific contextual factors—patient severity, provider for-profit/not-for-profit status, and provider financial pressure—reviewers graded the strength of evidence on one outcome, utilization, as “low.” The primary reasons for this rating were risk of bias, risk of residual confounding, inconsistency of findings, and imprecision of findings. The strength of evidence for other contextual factors and study outcomes was rated insufficient due to lack of evidence.

Several important contextual factors were described in reviewed studies, but their impact was not directly assessed. Some bundled payment interventions were implemented in the context of simultaneous but independent health care spending reduction efforts, including payment reforms other than bundled payment. For example, the Medicare Resource-Based Relative Value Scale physician fee schedule was implemented in 1992, overlapping with the time periods examined in several of the reviewed studies. Capitation and the spread of health maintenance organizations are two other examples of reforms that occurred during the time period of reviewed bundled payment programs. Due to the study designs used, studies were not able to differentiate the effects of bundled payment programs from related but independent interventions.

None of the reviewed studies provides insight into differential results by the degree of integration between health care delivery organizations and payers or between various health care delivery organizations. As noted above, most reviewed bundled payment interventions applied to a specific outpatient care setting or to inpatient environments where hospital and physician payments are not integrated. None of the reviewed studies reported on the effects of payer or provider competitive environments.

Applicability

The main intended audience for this report is policymakers, payers, and providers in the United States that are considering implementation of a bundled payment program. The findings of this review are likely to be applicable most directly to those considering a bundled payment program targeting single providers. The majority of bundled payment programs in the included studies focused on single institutional providers, such as inpatient hospitals, skilled nursing facilities, or inpatient rehabilitation facilities.

Recent interest in bundled payment has focused mostly on programs that bundle payments for multiple providers and/or provider types. The findings of this review are less applicable to these types of programs. There were several reviewed studies of bundled payment across multiple settings, but these included a small number of participating provider organizations that are not representative of the U.S. delivery system. More evidence is likely to be available in the future as evaluations of ongoing programs, such as the Medicare Acute Care Episode Demonstration, are published.

The interventions studied were typically specific to a single payer, most often Medicare or various public insurance systems outside the United States. The applicability of findings in studies involving one payer (e.g., Medicare) to other payer contexts is limited due to differences in beneficiary characteristics, provider bargaining power, and competitive pressures.

Interventions implemented in countries other than the United States may have limited applicability to the U.S. context due to differences in health system organization, financing, and delivery. Although non-U.S. studies were screened for comparability with a U.S. delivery setting, in practice this criterion was difficult to apply and no studies were excluded on the basis of nationality.

All reviewed studies assessed the impact of bundled payment relative to either fee-for-service or cost-based payment. The magnitude and direction of effects relative to fee-for-service or cost-based payment may differ from absolute effects. For example, bundled payment might slow an increase in absolute spending relative to usual payment. Transitions to bundled payment from other payment methods (e.g., salary or capitation) may have other effects.

Finally, evidence on bundled payment applies specifically to cases in which reimbursement based on episodes of care is both reasonable and feasible. Bundled payment may be less feasible or effective when applied to health care related to conditions without clearly defined treatment regimens, conditions with multiple treatment approaches, or rare conditions.

Recommendations for Further Research

There are several ways that future evaluations could produce a stronger evidence base. Policymakers and evaluation researchers must recognize the tension between producing timely practical evidence and conducting rigorous evaluations. The most rigorous study designs are usually feasible only when policymakers plan for an evaluation experiment in the course of implementation. We focus our recommendations on improving retrospective quasi-experimental studies, which formed the bulk of research reviewed for this report.

Use stronger evaluation study designs. Most reviewed studies used a pre-post design with no comparison group and a relatively short post period. Use of stronger study designs, such as difference-in-differences analyses with randomized control and intervention groups, would reduce risk of bias. The benefits to validity from including a comparison group likely outweigh the associated increase in evaluation time and cost.

Most studies considered a brief time horizon (less than 2 years) after the implementation of bundled payment systems. Given the challenges in implementation and redesign of care processes reported in studies with qualitative components, a longer time horizon is likely necessary to observe many important impacts. However, the benefits of a longer time horizon must be balanced against the need for rapid information on program effects and the risk of attributing changes due to secular variation to the payment intervention. Future evaluations could balance these needs by reporting at several points in time after intervention.

Practical data, time, and funding constraints often dictate the choice of evaluation study design. The limitations intrinsic to retrospective observational studies prevent the reviewed studies from approaching the “gold standard” equivalent of a randomized controlled trial. However, the two studies rated good and several studies rated fair outlined natural experiments or quasi-experimental strategies to identify the effect of bundled payment on spending and quality outcomes. Future evaluations should consider these and related methods that could improve evaluation validity with little effect on the timeliness of results.

Use standardized measures of impact on costs and quality. The measures used varied across studies. While different measures are likely more relevant to different interventions and implementations, increased consistency in the use of measures could increase the comparability of future evaluations of the impact of bundled payment. Collaboratives of evaluators, such as the Patient-Centered Medical Home Evaluators’ Collaborative, are one potential mechanism for identifying priority measurement areas and measurement approaches. Evaluation sponsors could also encourage evaluators to use standard measurement approaches or to collaborate with evaluators of similar interventions to harmonize measurement approaches.

Use stratification to understand the impact of bundled payment on specific patient groups. Few studies reported results for patient subgroups, but several that did so found significant differences in effects between subgroups. Future research on the impact of payment system changes should focus on specific patient populations (e.g., relatively seriously ill patients) and types of service.

Incorporate quantitative and qualitative measures of program design and contextual factors. This type of evidence will be critical as Medicare and private payers experiment with various payment and delivery reforms, including not only bundled payment but also reforms that include global payment or shared savings for accountable care organizations, and as they seek to identify which aspects of these pilots have the potential to be scaled widely. Important design features to be addressed include the definition of the bundle (How many providers are included? What is the length of time? Which services are included and excluded from the bundle?); methods for limiting financial risk, including risk adjustment and outlier payments; use of quality measurement; and methods for distributing payment among participating providers. Important contextual factors to be addressed include whether bundled payment is more effective in more highly integrated delivery settings, the role of financial pressure and the general financial environment on responses to bundled payment, and differential effects between subgroups of patients.

Incorporate measurement of ancillary or spillover effects. Only a handful of studies explored broader consequences of bundled payment beyond the setting of care or patient group targeted by the intervention. Several reviewed studies demonstrated that bundled payment programs had effects on other settings and patient groups. Future evaluations should be designed to detect these effects.

Conclusion

In summary, the introduction of bundled payment was associated with (1) reductions in health care spending and utilization, and (2) inconsistent and generally small effects on quality measures. These findings were consistent across different bundled payment programs and settings, but the strength of the body of evidence was rated as low, due mainly to concerns about bias and residual confounding.

These findings were subject to several important limitations. Most of the bundled payment interventions studied in reviewed articles (16/20) were limited to payments to single institutional providers (e.g., hospitals, skilled nursing facilities) and so have limited generalizability to newer programs that include multiple providers and/or multiple provider types. Exclusion criteria and the search strategy we used may have omitted some relevant studies from the results. The review is limited by the quality of the underlying studies. The interventions studied were often incompletely described in the reviewed articles.

For policymakers considering implementation of bundled payment programs, this evidence provides some support that the programs are likely to be an effective strategy for reducing health care spending. While the effects on health care quality are less certain, the available evidence does not support concerns about the worst potential adverse effects of bundled payment.

Policymakers considering bundled payment programs should also consider several caveats, however. First, future bundled payment programs are likely to differ in important ways from those reviewed in this study. Most of the programs reviewed were single-setting prospective payment systems that replaced fee-for-service reimbursement systems. In contrast, recent and forthcoming bundled payment programs, such as the Medicare national bundled payment initiative, focus on bundling services provided by different providers over the course of an episode defined by a condition, diagnosis, or procedure. The few completed studies of programs involving payment for multiple providers found evidence for reduced costs and inconsistent impacts on quality, although there were some reports of implementation difficulty. These programs are likely to be more complex than most of the reviewed programs and therefore may have different effects. Nevertheless, multiple-setting programs present a logical next step building on the largely positive effects of previous single-setting bundled payment programs.

Second, although evidence of effects on quality was inconsistent, bundled payment has the potential to either adversely affect quality or be used as part of a quality improvement strategy. Future bundled payment programs should incorporate a robust quality monitoring and improvement component, potentially as an integrated part of the payment system.

Third, the strength of evidence on bundled payment effects was low, reflecting the difficulty in evaluating large-scale policy interventions that occur in a rapidly changing health care system. Better information from evaluations could improve the impact of bundled payment programs, in particular by illustrating how the programs could be adapted for adoption in the variety of health care delivery contexts found in the United States.

References

  1. Medicare Payment Advisory Commission. Report to the Congress: Reforming the Delivery System; June 2008. medpac.gov/documents/jun08_entirereport.pdf.
  2. Dudley RA, Frolich A, Robinowitz DL, et al. Strategies To Support Quality-based Purchasing: A Review of the Evidence (Prepared by the Stanford-University of California San Francisco Evidence-based Practice Center under Contract No. 290-02-0057). AHRQ Publication No. 04-0057. Rockville, MD: Agency for Healthcare Research and Quality. July 2004.
  3. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Social Behav. 1995;36(1):1-10.
  4. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. www.effectivehealthcare.ahrq.gov.
  5. Cheh V. The Final Evaluation Report on the National Home Health Prospective Payment Demonstration: Agencies Reduce Visits While Preserving Quality. Princeton: Mathematica Policy Research, Inc.; April 30, 2001.
  6. Chulis GS. Assessing Medicare’s prospective payment system for hospitals. Med Care Rev. 1991 Summer;48(2):167-206. PMID: 10113662.
  7. Coulam R, Gaumer G. Medicare’s Prospective Payment System: a critical appraisal. Health Care Financ Rev Annual Supplement. 1991;13(2):45-77.
  8. Feinglass J, Holloway JJ. The initial impact of the Medicare prospective payment system on U.S. health care: a review of the literature. Med Care Rev. 1991 Spring;48(1):91-115. PMID: 10113596.
  9. Lave JR. The effect of the Medicare prospective payment system. Annu Rev Public Health. 1989;10:141-61. PMID: 2655628.
  10. Afendulis CC, Kessler DP. Vertical integration and optimal reimbursement policy. Int J Health Care Finance Econ. 2011;2011(11):165-79.
  11. Buntin MB, Colla CH, Escarce JJ. Effects of payment changes on trends in post-acute care. Health Serv Res. 2009 Aug;44(4):1188-210. PMID: 19490159.
  12. Chen LW, Shea DG. Does prospective payment really contain nursing home costs? Health Serv Res. 2002 Apr;37(2):251-71. PMID: 12035993.
  13. Collins T, Herness J, Martenas J, et al. Medicare prospective payment before and after implementation: a review of visits and physical performance among Medicare home health patients after total knee replacements. Home Healthc Nurse. 2007 Jun;25(6):401-7. PMID: 17556923.
  14. Grabowski DC, Afendulis CC, McGuire TG. Medicare prospective payment and the volume and intensity of skilled nursing facility services. J Health Econ. 2011 Jul;30(4):675-84. Epub 2011 Jun 6. PMID: 21705100.
  15. Hutt E, Ecord M, Eilertsen TB, et al. Prospective payment for nursing homes increased therapy provision without improving community discharge rates. J Am Geriatr Soc. 2001 Aug;49(8):1071-9.
  16. Konetzka R, Norton E, Sloane P, et al. Medicare prospective payment and quality of care for long-stay nursing facility residents. Med Care. 2006;44(3):270-6.
  17. Konetzka R, Norton E, Stearns S. Medicare payment changes and nursing home quality: effects on long-stay residents. Int J Health Care Finance Econ. 2006;6(3):173-89.
  18. Konetzka R, Yi D, Norton E, et al. Effects of Medicare payment changes on nursing home staffing and deficiencies. Health Serv Res. 2004;39(3):463-87.
  19. Kulesher RR, Wilder MG. Prospective payment and the provision of post-acute care: how the provisions of the Balanced Budget Act of 1997 altered utilization patterns for Medicare providers. J Health Care Finance. 2006 Fall;33(1):1-16. PMID: 21110487.
  20. Lapane KL, Hughes CM. An evaluation of the impact of the prospective payment system on antidepressant use in nursing home residents. Med Care. 2004 Jan;42(1):48-58. PMID: 14713739.
  21. Lapane KL, Hughes CM. Did the introduction of a prospective payment system for nursing home stays reduce the likelihood of pharmacological management of secondary ischaemic stroke? Drugs Aging. 2006;23(1):61-9. PMID: 16492070.
  22. Murray PK, Love TE, Dawson NV, et al. Rehabilitation services after the implementation of the nursing home prospective payment system: differences related to patient and nursing home characteristics. Med Care. 2005 Nov;43(11):1109-15. PMID: 16224304.
  23. White C. Rehabilitation therapy in skilled nursing facilities: effects of Medicare’s new prospective payment system. Health Aff (Millwood). 2003 May-Jun;22(3):214-23. PMID: 12757287.
  24. White C. Medicare’s prospective payment system for skilled nursing facilities: effects on staffing and quality of care. Inquiry. 2005 Winter;42(4):351-66. PMID: 16568928.
  25. Wodchis WP. Physical rehabilitation following Medicare prospective payment for skilled nursing facilities. Health Serv Res. 2004 Oct;39(5):1299-318. PMID: 15333110.
  26. Wodchis WP, Fries BE, Hirth RA. The effect of Medicare’s prospective payment system on discharge outcomes of skilled nursing facility residents. Inquiry. 2004 Winter;41(4):418-34. PMID: 15835600.
  27. Yip JY, Wilber KH, Myrtle RC. The impact of the 1997 Balanced Budget Amendment’s prospective payment system on patient case mix and rehabilitation utilization in skilled nursing. Gerontologist. 2002 Oct;42(5):653-60. PMID: 12351800.
  28. Zhang NJ, Unruh L, Wan TT. Has the Medicare prospective payment system led to increased nursing home efficiency? Health Serv Res. 2008 Jun;43(3):1043-61. PMID: 18454780.
  29. Zinn J, Feng Z, Mor V, et al. Restructuring in response to case mix reimbursement in nursing homes: a contingency approach. Health Care Manage Rev. 2008 Apr-Jun;33(2):113-23. PMID: 18360162.
  30. Dobrez D, Heinemann AW, Deutsch A, et al. Impact of Medicare’s prospective payment system for inpatient rehabilitation facilities on stroke patient outcomes. Am J Phys Med Rehabil. 2010 Mar;89(3):198-204. PMID: 20068431.
  31. Frymark TB, Mullen RC. Influence of the prospective payment system on speech-language pathology services. Am J Phys Med Rehabil. 2005 Jan;84(1):12-21. PMID: 15632484.
  32. DeJong G, Horn SD, Smout RJ, et al. The early impact of the inpatient rehabilitation facility prospective payment system on stroke rehabilitation case mix, practice patterns, and outcomes. Arch Phys Med Rehabil. 2005 Dec;86(12 Suppl 2):S93-S100. PMID: 16373144.
  33. Gillen R, Tennen H, McKee T. The impact of the inpatient rehabilitation facility prospective payment system on stroke program outcomes. Am J Phys Med Rehabil. 2007 May;86(5):356-63. PMID: 17449980.
  34. McCue MJ, Thompson JM. Early effects of the prospective payment system on inpatient rehabilitation hospital performance. Arch Phys Med Rehabil. 2006 Feb;87(2):198-202. PMID: 16442972.
  35. Paddock SM, Escarce JJ, Hayden O, et al. Did the Medicare inpatient rehabilitation facility prospective payment system result in changes in relative patient severity and relative resource use? Med Care. 2007 Feb;45(2):123-30. PMID: 17224774.
  36. Qu H, Shewchuk RM, Chen Y, et al. Impact of Medicare prospective payment system on acute rehabilitation outcomes of patients with spinal cord injury. Arch Phys Med Rehabil. 2011 Mar;92(3):346-51. PMID: 21353819.
  37. Shah P, Heinemann A, Manheim L. The effect of Medicare’s prospective payment system on patient satisfaction: an illustration with four rehabilitation hospitals. Am J Phys Med Rehabil. 2007;86(3):169-75.
  38. Sood N, Buntin MB, Escarce JJ. Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system. J Health Econ. 2008 Jul;27(4):1046-59. PMID: 18423657.
  39. Anderson MA, Clarke MM, Helms LB, et al. Hospital readmission from home health care before and after prospective payment. J Nurs Scholarsh. 2005;37(1):73-9. PMID: 15813590.
  40. Davitt JK, Choi S. The impact of policy on nursing and allied health services. Lessons from the Medicare home health benefit. Res Gerontol Nurs. 2008 Jan;1(1):4-13. PMID: 20078013.
  41. Eaton MK. The influence of a change in Medicare reimbursement on the effectiveness of stage III or greater decubitus ulcer home health nursing care. Policy Polit Nurs Pract. 2005 Feb;6(1):39-50. PMID: 16443958.
  42. FitzGerald JD, Boscardin WJ, Ettner SL. Changes in regional variation of Medicare home health care utilization and service mix for patients undergoing major orthopedic procedures in response to changes in reimbursement policy. Health Serv Res. 2009 Aug;44(4):1232-52. PMID: 19500167.
  43. FitzGerald JD, Mangione CM, Boscardin J, et al. Impact of changes in Medicare home health care reimbursement on month-to-month home health utilization between 1996 and 2001 for a national sample of patients undergoing orthopedic procedures. Med Care; 2006 Sep;44(9):870-8. PMID: 16932139.
  44. Lin CJ, Davitt JK, Meit M, et al. The financial impact of interim and prospective payment systems on home health providers in rural communities. J Health Care Poor Underserved. 2005 Aug;16(3):576-87. PMID: 16086009.
  45. Lin CJ, Meit M. Changes in Medicare home health care use and practices in rural communities: 1997 to 2001. J Aging Health. 2005 Jun;17(3):351-62. PMID: 15857963.
  46. Murtaugh CM, McCall N, Moore S, et al. Trends in Medicare home health care use: 1997-2001. Health Aff (Millwood). 2003 Sep-Oct;22(5):146-56. PMID: 14515890.
  47. Schlenker RE, Powell MC, Goodrich GK. Initial home health outcomes under prospective payment. Health Serv Res. 2005 Feb;40(1):177-93. PMID: 15663708.
  48. Nayar P. The impact of Medicare’s prospective payment system on staffing of long-term acute care hospitals: the early evidence. Health Care Manage Rev. 2008 Jul-Sep;33(3):264-73. PMID: 18580306.
  49. Menke TJ, Ashton CM, Petersen NJ, et al. Impact of an all-inclusive diagnosis-related group payment system on inpatient utilization. Med Care. 1998 Aug;36(8):1126-37. PMID: 9708587.
  50. Coburn AF, Fortinsky R, McGuire C, et al. Effect of prospective reimbursement on nursing home costs. Health Serv Res. 1993 Apr;28(1):45-68.
  51. Ellis R, McGuire T. Hospital response to prospective payment: moral hazard, selection, and practice-style effects. J Health Econ. 1996;15:257-77.
  52. Rosenthal MB. Risk sharing in managed behavioral health care. Health Aff. 1999;18(5):204-13.
  53. Rosenthal MB. Risk sharing and the supply of mental health services. J Health Econ. 2000;19:1047-65.
  54. Perelman J, Closon MC. Hospital response to prospective financing of in-patient days: the Belgian case. Health Policy. 2007 Dec;84(2-3):200-9. PMID: 17624469.
  55. Farrar S, Yi D, Sutton M, et al. Has payment by results affected the way that English hospitals provide care? Difference-in-differences analysis. BMJ. 2009;339:b3407.
  56. Brizioli E, Fraticelli A, Marcobelli A, et al. Hospital payment system based on diagnosis related groups in Italy: early effects on elderly patients with heart failure. Arch Gerontol Geriatr. 1996 Nov-Dec;23(3): 347-55.
  57. Hasegawa T, Bragg-Gresham JL, Pisoni RL, et al. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. Kidney Int. 2011 Feb;79(3):340-6. PMID: 20962740.
  58. Vos L, Duckers M, Wagner C, et al. Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Health Policy. 2010;98:74-80.
  59. Stromberg L, Ohlen G, Svensson O. Prospective payment systems and hip fracture treatment costs. Acta Orthop Scand. 1997 Feb;68(1):6-12. PMID: 9057560.
  60. Chen BH, Liu HW, Huang SL, et al. Comparison of appendectomy medical expense and clinical outcome between fee for service and prospective payment system. Kaohsiung J Med Sci. 2000 Jun;16(6):293-8. PMID: 11584430.
  61. Tsai YW, Chuang YC, Huang WF, et al. The effect of changing reimbursement policies on quality of in-patient care, from fee-for-service to prospective payment. Int J Qual Health Care. 2005 Oct;17(5):421-6. PMID: 15985506.
  62. Wen YP, Wen SY. Do closed-system hospitals shift care under case payment? Early experiences comparing five surgeries in Taiwan. Chang Gung Med J. 2008 Jan-Feb;31(1):91-101. PMID: 18419058.
  63. Casale A, Paulus R, Selna M, et al. “ProvenCareSM”: a provider-driven pay-for-performance program for acute episodic cardiac surgical care. Ann Surg. 2007 Oct;246(4):613-23.
  64. Cromwell J, Dayhoff DA, McCall N, et al. Medicare Participating Heart Bypass Center Demonstration: Final Report. Waltham, MA: Health Economics Research; July 24, 1998.
  65. Abt Associates. Medicare Cataract Surgery Alternate Payment Demonstration: Final Evaluation Report. Cambridge, MA:Abt Associates; June 13, 1997.
  66. Johnson LL, Becker RL. An alternative health-care reimbursement system—application of arthroscopy and financial warranty: results of a 2-year pilot study. Arthroscopy. 1994;10(4):462-70.

Full Report

This executive summary is part of the following document: Hussey PS, Mulcahy AW, Schnyer C, Schneider EC. Bundled Payment: Effects on Health Care Spending and Quality. Closing the Quality Gap: Revisiting the State of the Science. Evidence Report/Technology Assessment No. 208. (Prepared by the RAND Evidence-based Practice Center under Contract No. 290-2007-10062-I.) AHRQ Publication No. 12-E007-EF. Rockville, MD. Agency for Healthcare Research and Quality. August 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

For More Copies

For more copies of Bundled Payment: Effects on Health Care Spending and Quality. Closing the Quality Gap: Revisiting the State of the Science: Evidence Report/Technology Assessment Executive Summary No. 208 (AHRQ Publication No. 12-E007-1), please call the AHRQ Publications Clearinghouse at 800–358–9295 or email ahrqpubs@ahrq.gov.

Return to Top of Page